Managing Compliance Risks With Cloud-Native EAM/CMMS

Every system touchpoint in pharmaceutical asset management introduces compliance exposure under FDA data integrity requirements. Mobile offline workflows create audit trail gaps when technicians capture calibration data without WiFi, raising questions about timestamp accuracy and Part 11 controls. Integration failures between CMMS, LIMS, and QMS can allow out-of-tolerance instruments into production. Multi-site operations inherit fragmented systems that regulators identify during inspections. Cloud validation remains ambiguous for teams accustomed to on-premise qualification. Purpose-built platforms address these risks through embedded GMP controls—electronic signatures carry identical Part 11 protections online or offline, automated workflows generate nonconformance reports when calibrations fail, and change control gates prevent unauthorized equipment modifications.

Discover how cloud-native architecture transforms compliance from manual configuration into code-level controls that make the compliant path the default operational path.